Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

850 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments.
Naye F, Toupin-April K, de Wit M, LeBlanc A, Dubois O, Boonen A, Barton JL, Fraenkel L, Li LC, Stacey D, March L, Barber CEH, Hazlewood GS, Guillemin F, Bartlett SJ, Berthelsen DB, Mather K, Arnaud L, Akpabio A, Adebajo A, Schultz G, Sloan VS, Gill TK, Sharma S, Scholte-Voshaar M, Caso F, Nikiphorou E, Nasef SI, Campbell W, Meara A, Christensen R, Suarez-Almazor ME, Jull JE, Alten R, Morgan EM, El-Miedany Y, Singh JA, Burt J, Jayatilleke A, Hmamouchi I, Blanco FJ, Fernandez AP, Mackie S, Jones A, Strand V, Monti S, Stones SR, Lee RR, Nielsen SM, Evans V, Srinivasalu H, Gérard T, Demers JL, Bouchard R, Stefan T, Dugas M, Bergeron F, Beaton D, Maxwell LJ, Tugwell P, Décary S. Naye F, et al. Among authors: guillemin f. Semin Arthritis Rheum. 2024 Apr;65:152344. doi: 10.1016/j.semarthrit.2023.152344. Epub 2023 Dec 16. Semin Arthritis Rheum. 2024. PMID: 38232625 Review.
Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative.
Weinbrecht-Mischkewitz M, Kamal M, Asim F, Guillemin F, Goel N, Voshaar M, Boonen A, Berthelsen DB, Toupin-April K, Lopez-Olivo MA, Sloan VS, Boers M, Jones CA, van der Horst-Bruinsma I, Cashin AG, Sharma S, Leong A, Alten R, Shea B, March L, Tugwell P, Christensen R, Nielsen SM; Contextual Factors Working Group. Weinbrecht-Mischkewitz M, et al. Among authors: guillemin f. Semin Arthritis Rheum. 2024 Apr;65:152370. doi: 10.1016/j.semarthrit.2024.152370. Epub 2024 Jan 10. Semin Arthritis Rheum. 2024. PMID: 38290371 Free article.
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials.
Décary S, de Wit M, Naye F, Barton JL, Fraenkel L, Li LC, Brooks P, Stacey D, Maxwell LJ, Campbell W, Hofstetter C, Voshaar M, Meara A, Christensen R, Boonen A, Suarez-Almazor ME, Meade T, March L, Jull JE, Alten R, Morgan EM, Stewart Hazlewood G, Barber CEH, Guillemin F, El-Miedany Y, Mittoo S, Robertson TW, Bartlett SJ, Singh JA, Mannion M, Nasef SI, Boel A, Adebajo A, Arnaud L, Gill TK, Moholt E, Burt J, Jayatilleke A, Hmamouchi I, Berthelsen DB, Blanco FJ, Mather K, Maharaj A, Sharma S, Caso F, Beaton D, Shea B, Fong C, Fernandez AP, Mackie S, Nikiphorou E, Jones A, Greer-Smith R, Sloan VS, Akpabio A, Strand V, Lee RR, Umaefulam V, Monti S, Abaza N, Schultz G, Stones S, Gossec L, Nielsen SM, Cavallo S, Srinivasalu H, Constien D, Evans V, Tugwell P, Toupin-April K. Décary S, et al. Among authors: guillemin f. Semin Arthritis Rheum. 2024 Apr;65:152381. doi: 10.1016/j.semarthrit.2024.152381. Epub 2024 Jan 15. Semin Arthritis Rheum. 2024. PMID: 38306813
Assessing domain match and feasibility of candidate instruments matching with OMERACT endorsed domains to measure flare in knee and hip osteoarthritis.
Queiroga F, Cembalo SM, Epstein J, Maxwell L, Buttel T, Copenhaver C, Cross M, Hunter D, King L, Callahan L, March L, Beaton DE, Guillemin F; Flares in OA working group. Queiroga F, et al. Among authors: guillemin f. Semin Arthritis Rheum. 2024 Apr;65:152371. doi: 10.1016/j.semarthrit.2024.152371. Epub 2024 Feb 1. Semin Arthritis Rheum. 2024. PMID: 38340607 Review.
Evolving and evaluating the OMERACT fellows program: insights and implications from OMERACT 2023 fellows.
Chapman LS, Kelly A, Balay-Dustrude E, Bekker C, Berthelsen DB, Ghosh N, Gordon RA, Haas R, Jones C, Luquini A, Weinbrecht-Mischkewitz M, Pickles T, Saygin D, Nielsen W, Webers C, Grosskleg S, Tugwell P, D'Agostino MA, Guillemin F, March L. Chapman LS, et al. Among authors: guillemin f. Semin Arthritis Rheum. 2024 Apr;65:152391. doi: 10.1016/j.semarthrit.2024.152391. Epub 2024 Feb 4. Semin Arthritis Rheum. 2024. PMID: 38340612 Free article.
Embracing unity at OMERACT: Valuing equity, promoting diversity, fostering inclusivity.
Maxwell LJ, Wright GC, Schultz G, Grosskleg S, Barton JL, Campbell W, Guillemin F, Hofstetter C, Shea BJ, Simon LS, Adebajo A, Barnabe C, Goel N, Hurley P, Nikiphorou E, Petkovic J, Tugwell P. Maxwell LJ, et al. Among authors: guillemin f. Semin Arthritis Rheum. 2024 Jun;66:152422. doi: 10.1016/j.semarthrit.2024.152422. Epub 2024 Feb 29. Semin Arthritis Rheum. 2024. PMID: 38461757
Advancing composite outcome measures: Insights on weighting components from OMERACT 2023.
Wells GA, Guillemin F, Merkel PA, de Wit M, Mackie S, March L, Tómasson G, King LK, Cembalo SM, Grosskleg S, Maxwell LJ, Monti S, Quinn KA, Shea BJ, Tugwell P, Beaton D. Wells GA, et al. Among authors: guillemin f. Semin Arthritis Rheum. 2024 Dec;69:152503. doi: 10.1016/j.semarthrit.2024.152503. Epub 2024 Jun 30. Semin Arthritis Rheum. 2024. PMID: 39236373
Building a composite score for patient self-report of flare in osteoarthritis: a comparison of methods with the Flare-OA-16 questionnaire.
Queiroga F, Epstein J, Erpelding ML, Soudant M, King L, Spitz E, Maillefert JF, Fautrel B, Callahan LF, March L, Hunter DJ, Guillemin F. Queiroga F, et al. Among authors: guillemin f. J Clin Epidemiol. 2024 Oct;174:111467. doi: 10.1016/j.jclinepi.2024.111467. Epub 2024 Jul 26. J Clin Epidemiol. 2024. PMID: 39067540 Free article.
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision Analysis.
Barbhaiya M, Zuily S, Amigo MC, Andrade D, Avcin T, Bertolaccini ML, Branch DW, Costedoat-Chalumeau N, Crowther M, Ramires de Jesus G, Devreese KMJ, Frances C, Garcia D, Gómez-Puerta JA, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Petri M, Sanna G, Sciascia S, Seshan SV, Tektonidou MG, Wahl D, Willis R, Yelnik C, Hendry A, Naden R, Costenbader K, Erkan D; ACR/EULAR APS Classification Criteria Collaborators. Barbhaiya M, et al. Among authors: guillemin f. Arthritis Care Res (Hoboken). 2024 Dec;76(12):1617-1625. doi: 10.1002/acr.25415. Epub 2024 Sep 30. Arthritis Care Res (Hoboken). 2024. PMID: 39135467
850 results